Latest advances in cone-beam CT for bladder radiotherap

Imaging in Medicine

Volumn 3, Issue 3, 2011, Pages 321-332

  Harris, Victoria A ^a   McDonald, Fiona M A ^a   Huddart, Robert ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

bladder cancer; cone beam CT scan; image guided adaptive radiotherapy

Indexed keywords

IODINATED POPPYSEED OIL;

ANISOTROPY; ARTIFACT; BLADDER CANCER; BLADDER CAPACITY; BLADDER CATHETERIZATION; BLADDER DISEASE; BLADDER FILLING; BLADDER MUCOSA; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CONE BEAM COMPUTED TOMOGRAPHY; CYSTECTOMY; CYSTOSCOPY; DIAGNOSTIC IMAGING; HUMAN; HYSTEROSALPINGOGRAPHY; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTENSITY MODULATED RADIATION THERAPY; LYMPHOGRAPHY; MEASUREMENT ERROR; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REVIEW; ROTATION; SURVIVAL TIME; TARGET ORGAN;

EID: 79959424716     PISSN: 17555191     EISSN: 17555205     Source Type: Journal    
DOI: 10.2217/iim.11.20     Document Type: Review

References (58)

1. Cookson MS: The surgical management of muscle invasive bladder cancer: a contemporary review. Semin. Radiat. Oncol. 15, 10-18 (2005 (Pubitemid 40127274)
2. Hall CM, Dinney CP: Radical cystectomy for stage T3b bladder cancer. Semin. Urol. Oncol. 14(2), 73-80 (1996 (Pubitemid 26154974)
3. Smith JA Jr, Crawford ED, Paradelo JC et al.: Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a Phase III intergroup study. J. Urol. 157(3), 805-807 (1997
4. Stimson CJ, Chang SS, Barocas DA et al.: Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J. Urol. 184(4), 1296-1300 (2010
5. Hautmann RE, Simon J: Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men. J. Urol. 162(6), 1963-1966 (1999
6. James ND: Results of a Phase III randomized trial of synchronous chemoradiotherapy (CRT) compared to radiotherapy (RT) alone in muscle-invasive bladder cancer (MIBC) (BC2001 CRUK/01/004Int. J. Radiat. Oncol. Biol. Phys. 78(3), S2-S3 (2010
7. Huddart RA, Hall E, Lewis R, Birtle A: Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed. BJU Int. 106(6), 753-755 (2010
8. Rodel C, Grabenbauer GG, Kuhn R et al.: Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J. Clin. Oncol. 20(14), 3061-3071 (2002). (Pubitemid 34791095)
9. Stein JP, Lieskovsky G, Cote R et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol. 19(3), 666-675 (2001 (Pubitemid 32120143)
10. Kotwal S, Choudhury A, Johnston C, Paul AB, Whelan P, Kiltie AE: Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Int. J. Radiat. Oncol. Biol. Phys. 70(2), 456-463 (2008
11. Advanced Bladder Cancer Meta-analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361(9373), 1927-1934 (2003
12. Choudhury A, Swindell R, Logue JP et al.: Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. J. Clin. Oncol. 29(6), 733-738 (2011
13. Emami B, Lyman J, Brown A et al.: Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21(1), 109-122 (1991
14. Korreman S, Rasch C, Mcnair H et al.: The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Radiother. Oncol. 94(2), 129-144 (2010)
15. Xing L, Chang J, Orton CG: Point/counterpoint. Kilovoltage imaging is more suitable than megavoltage imaging for guiding radiation therapy. Med. Phys. 34(12), 4563-4566 (2007 (Pubitemid 350197693)
16. Lotz HT, Remeijer P, Van Herk M et al.: A model to predict bladder shapes from changes in bladder and rectal filling. Med. Phys. 31(6), 1415-1423 (2004 (Pubitemid 38808509)
17. Sur RK, Clinkard J, Jones WG et al.: Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin. Oncol. (R. Coll. Radiol.) 5(1), 30-33 (1993 (Pubitemid 23069083)
18. Turner SL, Swindell R, Bowl N et al.: Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 39(2), 355-360 (1997
19. Harris SJ, Buchanan RB: An audit and evaluation of bladder movements during radical radiotherapy. Clin. Oncol. (R. Coll. Radiol.) 10(4), 262-264 (1998 (Pubitemid 28454548)
20. Pos FJ, Koedooder K, Hulshof MC, Van Tienhoven G, González González D: Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 55(3), 835-841 (2003 (Pubitemid 36170023)
21. Muren LP, Smaaland R, Dahl O: Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother. Oncol. 69(3), 291-304 (2003 (Pubitemid 37486004)
22. Meijer GJ, Rasch C, Remeijer P, Lebesque JV: Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 55(5), 1277-1287 (2003 (Pubitemid 36338294)
23. Fokdal L, Honore H, Hoyer M, Meldgaard P, Fode K, Von Der Maase H: Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 59(2), 436-444 (2004 (Pubitemid 38622598)
24. Redpath AT, Muren LP: CT-guided intensity-modulated radiotherapy for bladder cancer: isocentre shifts, margins and their impact on target dose. Radiother. Oncol. 81(3), 276-283 (2006 (Pubitemid 44856008)
25. Lotz HT, Pos FJ, Hulshof MC et al.: Tumor motion and deformation during external radiotherapy of bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 64(5), 1551-1558 (2006
26. Henry AM, Stratford J, Mccarthy C et al.: X-ray volume imaging in bladder radiotherapy verification. Int. J. Radiat. Oncol. Biol. Phys. 64(4), 1174-1178 (2006
27. Lalondrelle S, Huddart R, Warren-Oseni K et al.: Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 79(3), 705-712 (2011
28. Yee D, Parliament M, Rathee S, Ghosh S, Ko L, Murray B: Cone beam CT imaging analysis of interfractional variations in bladder volume and position during radiotherapy for bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 76(4), 1045-1053 (2010
29. Mangar SA, Miller NR, Khoo VS et al.: Evaluating inter-fractional changes in volume and position during bladder radiotherapy and the effect of volume limitation as a method of reducing the internal margin of the planning target volume. Clin. Oncol. (R. Coll. Radiol.) 20(9), 698-704 (2008
30. Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A: An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 48(1), 289-302 (2000 (Pubitemid 30488241)
31. Pos FJ, Hulshof M, Lebesque J et al.: Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int. J. Radiat. Oncol. Biol. Phys. 64(3), 862-868 (2006 (Pubitemid 43183586)
32. Burridge N, Amer A, Marchant T et al.: Online adaptive radiotherapy of the bladder: small bowel irradiated-volume reduction. Int. J. Radiat. Oncol. Biol. Phys. 66(3), 892-897 (2006 (Pubitemid 44436721)
33. Vestergaard A, Sondergaard J, Petersen JB, Hoyer M, Muren LP: A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer. Acta Oncol. 49(7), 1069-1076 (2010
34. Foroudi F, Wong J, Kron T et al.: Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study. Int. J. Radiat. Oncol. Biol. Phys. DOI: 101016/j. ijrobp.201006061 (2010) (Epub ahead of print
35. Mangar SA, Scurr E, Huddart RA et al.: Assessing intra-fractional bladder motion using cine-MRI as initial methodology for predictive organ localization (POLO) in radiotherapy for bladder cancer. Radiother. Oncol. 85(2), 207-214 (2007 (Pubitemid 350161003)
36. Mcdonald F, Lalondrelle S, Taylor H et al.: Delivering adaptive radiotherapy in the clinic: Preliminary experiences from the APPLY study [Adaptive-Predictive Planning for Hypo-Fractionated Bladder RT]. Radiother. Oncol. 96 (S1), 177 (2010
37. Lybeert ML, Ribot JG, De Neve W, Goor C, Crommelin MA: Carcinoma of the urinary bladder: long-term results of interstitial radiotherapy. Bull. Cancer Radiother. 81(1), 33-40 (1994 (Pubitemid 24091308)
38. Dearnaley DP, Khoo VS, Norman AR et al.: Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353(9149), 267-272 (1999 (Pubitemid 29088118)
39. Marks LB, Carroll PR, Dugan TC, Anscher MS: The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31(5), 1257-1280 (1995
40. Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU: Radiation dose-volume effects of the urinary bladder. Int. J. Radiat. Oncol. Biol. Phys. 76(3 Suppl.), S116-S122 (2010).
41. Mangar SA, Foo K, Norman A et al.: Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer. Clin. Oncol. (R. Coll. Radiol.) 18(6), 466-473 (2006 (Pubitemid 43942237)
42. Cowan RA, Mcbain CA, Ryder WD et al.: Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 59(1), 197-207 (2004 (Pubitemid 38501525)
43. Huddart R, Staffurth J: What is the most effective way of reducing normal tissue toxicity in radical radiotherapy treatment of muscle invasive bladder cancer. Radiother. Oncol. 64(S1), 305 (2002)
44. Mcdonald F, Rogers S, Hall E, James N, Huddart R: Defining bowel dose-volume constraints for bladder radiotherapy: using data from patients entered into a Phase III randomised trial. Eur. J. Cancer Suppl. 7(2), 163-164 (2009
45. Mangar S, Thompson A, Miles E, Huddart R, Horwich A, Khoo V: A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotherapy. Br. J. Radiol. 80(952), 279-283 (2007 (Pubitemid 47018382)
46. Hulshof MC, Van Andel G, Bel A, Gangel P, Van De Kamer JB: Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas. Radiother. Oncol. 84(1), 49-51 (2007 (Pubitemid 47030691)
47. Pos F, Bex A, Dees-Ribbers HM, Betgen A, Van Herk M, Remeijer P: Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer. Radiother. Oncol. 93(2), 364-367 (2009
48. Chai X, Van Herk M, Van De Kamer JB et al.: Behavior of Lipiodol markers during image guided radiotherapy of bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 77(1), 309-314 (2010
49. Kupelian P, Willoughby T, Mahadevan A et al.: Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 67(4), 1088-1098 (2007
50. Weiss E, Wu J, Sleeman W et al.: Clinical evaluation of soft tissue organ boundary visualization on cone-beam computed tomographic imaging. Int. J. Radiat. Oncol. Biol. Phys. 78(3), 929-936 (2010
51. Smitsmans MH, Pos FJ, De Bois J et al.: The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 71(4), 1279-1286 (2008 (Pubitemid 351842600)
52. Kron T, Wong J, Rolfo A, Pham D, Cramb J, Foroudi F: Adaptive radiotherapy for bladder cancer reduces integral dose despite daily volumetric imaging. Radiother. Oncol. 97(3), 485-487 (2010
53. Dearnaley DP, Sydes MR, Graham JD et al.: Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 8(6), 475-487 (2007 (Pubitemid 46805903)
54. Nutting C: Dose-escalation chemo-IMRT improves locoregional control rates in organ preservation treatment of locally advanced laryngeal and hypopharengeal cancers. Radiother. Oncol. 90(Suppl. 2), S11 (2009
55. 2-T3 bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 60(1), 60-70 (2004 (Pubitemid 39165469)
56. Muren LP, Redpath AT, Mclaren D et al.: A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy. Radiother. Oncol. 80(1), 98-105 (2006 (Pubitemid 44226437)
57. Hoskin PJ, Rojas AM, Bentzen SM, Saunders MI: Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma. J. Clin. Oncol. 28(33), 4912-4918 (2010
58. Cheung J, Aubry JF, Yom SS, Gottschalk AR, Celi JC, Pouliot J: Dose recalculation and the Dose-Guided Radiation Therapy (DGRT) process using megavoltage cone-beam CT. Int. J. Radiat. Oncol. Biol. Phys. 74(2), 583-592 (2009).